What Happened?
Shares of medicine and manufacturing technology provider Novanta (NASDAQ: NOVT) jumped 8% in the afternoon session after an analyst at William Blair gave the company a Buy rating. The analyst, Brian Drab, was noted for having a positive track record in the Industrial Goods sector, adding weight to the positive outlook.
The shares closed the day at $128.65, up 8.1% from previous close.
Is now the time to buy Novanta? Access our full analysis report here.
What Is The Market Telling Us
Novanta’s shares are somewhat volatile and have had 14 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 17 days ago when the stock dropped 3.1% on the news that investors grew anxious as the U.S. government shutdown extended into its seventh day, creating widespread uncertainty.
The political stalemate in Washington has tangible consequences for the economy and markets. A key impact is the delay in the release of crucial economic data, including the September jobs report, leaving the Federal Reserve with less information to guide its policy decisions. The shutdown is also causing direct disruptions, with staffing shortages at the Federal Aviation Administration (FAA) leading to widespread delays at major airports. This combination of economic ambiguity and real-world service interruptions has dampened investor confidence across multiple sectors.
Adding to the unease, Chief Economist at Moody's Analytics, Mark Zandi, warned that 22 states are already showing clear signs of a recession, placing the broader U.S. economy in a precarious position. Also, the latest Survey of Consumer Expectations from the New York Fed revealed that households' short-term inflation expectations are rising, while their outlook on the labor market is deteriorating. Consumers expressed greater concern about potential job losses and expect lower earnings growth, factors that directly impact discretionary spending.
Novanta is down 14.8% since the beginning of the year, and at $128.65 per share, it is trading 29.6% below its 52-week high of $182.65 from November 2024. Investors who bought $1,000 worth of Novanta’s shares 5 years ago would now be looking at an investment worth $1,152.
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
